Cargando…
Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer
Pathological complete response (pCR) is an accurate predictor of good outcome following neoadjuvant chemotherapy (NAC) for locally advanced breast cancer. The presence of circulating-tumor DNA (ctDNA) has recently been reported to be strongly predictive of poor outcome in similar patient groups. We...
Autores principales: | Butler, Timothy M., Boniface, Christopher T., Johnson-Camacho, Katie, Tabatabaei, Shaadi, Melendez, Daira, Kelley, Taylor, Gray, Joe, Corless, Christopher L., Spellman, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549569/ https://www.ncbi.nlm.nih.gov/pubmed/30833418 http://dx.doi.org/10.1101/mcs.a003772 |
Ejemplares similares
-
Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
por: Butler, Timothy M., et al.
Publicado: (2015) -
The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease
por: Boniface, Christopher, et al.
Publicado: (2021) -
Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
por: Boniface, Christopher T., et al.
Publicado: (2022) -
Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
por: Boniface, Christopher T., et al.
Publicado: (2023) -
Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples
por: Wagner, Josiah T., et al.
Publicado: (2020)